Latest news with #Valiquette
Business Insider
3 days ago
- Business
- Business Insider
Cencora (COR) Receives a Buy from Mizuho Securities
In a report released today, Steven Valiquette from Mizuho Securities maintained a Buy rating on Cencora (COR – Research Report), with a price target of $316.00. The company's shares opened today at $285.89. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Valiquette covers the Healthcare sector, focusing on stocks such as Align Tech, Cencora, and DENTSPLY SIRONA. According to TipRanks, Valiquette has an average return of 0.4% and a 54.81% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cencora with a $335.10 average price target, which is a 17.21% upside from current levels. In a report released on June 3, Wells Fargo also upgraded the stock to a Buy with a $337.00 price target. Based on Cencora's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $75.45 billion and a net profit of $717.87 million. In comparison, last year the company earned a revenue of $68.41 billion and had a net profit of $420.78 million Based on the recent corporate insider activity of 91 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of COR in relation to earlier this year. Earlier this month, Lazarus Krikorian, the SVP & CAO of COR sold 3,000.00 shares for a total of $866,880.80.
Business Insider
3 days ago
- Business
- Business Insider
Cardinal Health (CAH) Gets a Buy from Mizuho Securities
In a report released today, Steven Valiquette from Mizuho Securities maintained a Buy rating on Cardinal Health (CAH – Research Report), with a price target of $161.00. The company's shares opened today at $153.54. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Valiquette covers the Healthcare sector, focusing on stocks such as Align Tech, Cencora, and DENTSPLY SIRONA. According to TipRanks, Valiquette has an average return of 0.4% and a 54.81% success rate on recommended stocks. Cardinal Health has an analyst consensus of Strong Buy, with a price target consensus of $165.73, a 7.94% upside from current levels. In a report released on June 3, Leerink Partners also reiterated a Buy rating on the stock with a $177.00 price target.
Edmonton Journal
6 days ago
- General
- Edmonton Journal
'High glove': NHL goalie expert points out Florida star Bobrovsky's one weakness
Article content 'You've got to look at where to go on him,' said Valiquette, analyst for MSG and Clear Sight Analytics CEO, on the Real Kyper and Bourne podcast this week. 'You've got to go high glove on the breakaway, all right? Whether it's a deke or an early shot, that's where you have to go.' The Oilers had success on the breakaway against Bobrovsky in the 2024 Final, especially as the series went along. In the first three rounds of the playoffs, Edmonton had just six breakaways and scored one goal. Against Florida, Edmonton had 10 breakaways and scored six times, this according to the video review of all Grade A shots at the Cult of Hockey. That's an outstanding clearance rate on breakaways against Bobrovsky. Bobrovsky has been strong so far in the 2025 playoffs on breakaways, facing 18 and giving up just three goals, Valiequette said, but he had had the worst safe percentage on breakaways in the regular season. 'And Florida gives up a lot of breakaways. They ranked 27th in breakaways against. You're going to see breakaways against them.'
